{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:49:11Z","timestamp":1786592951688,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["GPP 2022"],"award-info":[{"award-number":["GPP 2022"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ero.2025.08.009","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:36:16Z","timestamp":1761377776000},"page":"339-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patients\u2019 perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trial"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-7345","authenticated-orcid":false,"given":"Peter A.","family":"Merkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8014-1801","authenticated-orcid":false,"given":"Bernhard","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6287-9549","authenticated-orcid":false,"given":"Christian","family":"Pagnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-1206","authenticated-orcid":false,"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3505-2946","authenticated-orcid":false,"given":"Michael E.","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Badenoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Hartsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0853-4210","authenticated-orcid":false,"given":"Vivian H.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"B\u00f6rjesson Sj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Necander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-9021","authenticated-orcid":false,"given":"Jennifer N.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6972-7802","authenticated-orcid":false,"given":"Eyra","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-9651","authenticated-orcid":false,"given":"Calvin N.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ero.2025.08.009_bib0001","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.ero.2025.08.009_bib0002","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr2.11263","article-title":"Clinical manifestations and long-term outcomes of eosinophilic granulomatosis with polyangiitis in North America","volume":"3","author":"Doubelt","year":"2021","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.08.009_bib0003","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.08.009_bib0004","article-title":"Eosinophilic granulomatosis with polyangiitis - advances in pathogenesis, diagnosis, and treatment","volume":"10","author":"Fijolek","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"suppl 3","key":"10.1016\/j.ero.2025.08.009_bib0005","doi-asserted-by":"crossref","first-page":"iii84","DOI":"10.1093\/rheumatology\/kez570","article-title":"Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management","volume":"59","author":"Trivioli","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ero.2025.08.009_bib0006","first-page":"40","article-title":"Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study","volume":"35","author":"Benarous","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.ero.2025.08.009_bib0007","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.ero.2025.08.009_bib0008","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ero.2025.08.009_bib0009","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/rheumatology\/kep103","article-title":"Assessment of damage in vasculitis: expert ratings of damage","volume":"48","author":"Seo","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ero.2025.08.009_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/ard.2008.097758","article-title":"Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis","volume":"68","author":"Merkel","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ero.2025.08.009_bib0011","first-page":"877","article-title":"Patients and clinicians have different perspectives on outcomes in arthritis","volume":"30","author":"Hewlett","year":"2003","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.ero.2025.08.009_bib0012","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/acr.20276","article-title":"Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective","volume":"62","author":"Herlyn","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.ero.2025.08.009_bib0013","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/acr.22069","article-title":"Illness perceptions and fatigue in systemic vasculitis","volume":"65","author":"Grayson","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.ero.2025.08.009_bib0014","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/rheumatology\/kead199","article-title":"Association of the AAV-PRO questionnaire with established outcome measures in AAV","volume":"63","author":"Maunz","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.ero.2025.08.009_bib0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0885-3924(02)00518-3","article-title":"Patient-related barriers to fatigue communication: initial validation of the fatigue management barriers questionnaire","volume":"24","author":"Passik","year":"2002","journal-title":"J Pain Symptom Manage"},{"issue":"20","key":"10.1016\/j.ero.2025.08.009_bib0016","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ero.2025.08.009_bib0017","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ero.2025.08.009_bib0018","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1159\/000526410","article-title":"Effectiveness of low-dose mepolizumab in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA): a real-life experience","volume":"183","author":"\u00d6zdel \u00d6zturk","year":"2022","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.ero.2025.08.009_bib0019","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"6","key":"10.1016\/j.ero.2025.08.009_bib0020","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2010.04.004","article-title":"MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function","volume":"125","author":"Kolbeck","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ero.2025.08.009_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003956","article-title":"Prospective study of complications and sequelae of glucocorticoid therapy in ANCA-associated vasculitis","volume":"10","author":"Scherbacher","year":"2024","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.ero.2025.08.009_bib0022","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1007\/s12325-019-01070-w","article-title":"Oral corticosteroid use for the treatment of chronic eosinophilic disease: a patient\u2019s and his physician\u2019s experience","volume":"36","author":"Silva","year":"2019","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.ero.2025.08.009_bib0023","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13023-018-0969-1","article-title":"Patient involvement in medical research: what patients and physicians learn from each other","volume":"14","author":"Young","year":"2019","journal-title":"Orphanet J Rare Dis"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:03:23Z","timestamp":1778940203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125000722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S3050708125000722"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.08.009","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients\u2019 perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trial","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}